ASND
Price:
$230.83
Market Cap:
$12.49B
Ascendis Pharma A/S is a biopharmaceutical enterprise dedicated to advancing therapeutic solutions for critical medical conditions that currently lack effective treatments. Its commercialized offering is SKYTROFA, a therapy prescribed for individuals suffering from growth hormone deficiency (GHD). The company boasts a robust development pipeline, featuring several TransCon-branded candidates. These include TransCon Growth Hormone (hGH), which is being progressed for pediatric GHD patients in Japan and for adults with GHD. Also under development are TransCon parathyroid hormone for adults with hypoparathyroidism, and TransCon CNP, aimed at treating pediatric achondroplasia. Further expanding ...[Read more]
Industry
Biotechnology
IPO Date
2015-01-28
Stock Exchange
NASDAQ
Ticker
ASND
According to Ascendis Pharma A/S’s latest financial reports and current stock price. The company's current ROE is -5641.90%. This represents a change of -10995.21% compared to the average of 51.78% of the last 4 quarters.
The mean historical ROE of Ascendis Pharma A/S over the last ten years is 32.00%. The current -5641.90% ROE has changed -17733.66% with respect to the historical average. Over the past ten years (40 quarters), ASND's ROE was at its highest in in the September 2023 quarter at 220.91%. The ROE was at its lowest in in the June 2023 quarter at -187.28%.
Average
32.00%
Median
-41.10%
Minimum
-221.45%
Maximum
357.68%
Discovering the peaks and valleys of Ascendis Pharma A/S ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 410.16%
Maximum Annual ROE = 357.68%
Minimum Annual Increase = -249.22%
Minimum Annual ROE = -221.45%
| Year | ROE | Change |
|---|---|---|
| 2025 | 134.58% | -62.37% |
| 2024 | 357.68% | 8.24% |
| 2023 | 330.44% | -249.22% |
| 2022 | -221.45% | 410.16% |
| 2021 | -43.41% | -13.10% |
| 2020 | -49.95% | 36.81% |
| 2019 | -36.51% | -21.40% |
| 2018 | -46.45% | -29.81% |
| 2017 | -66.18% | 70.62% |
| 2016 | -38.79% | 41.77% |
The current ROE of Ascendis Pharma A/S (ASND) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
274.23%
5-year avg
111.57%
10-year avg
32.00%
Ascendis Pharma A/S’s ROE is greater than Ionis Pharmaceuticals, Inc. (-58.57%), less than BridgeBio Pharma, Inc. (36.00%), greater than Revolution Medicines, Inc. (-83.22%), less than Roivant Sciences Ltd. (-6.85%), greater than Summit Therapeutics Inc. (-340.55%), less than Guardant Health, Inc. (184.27%), less than Madrigal Pharmaceuticals, Inc. (-50.15%), less than Exelixis, Inc. (40.21%), less than BioMarin Pharmaceutical Inc. (4.41%), less than Moderna, Inc. (-36.73%),
| Company | ROE | Market cap |
|---|---|---|
| -58.57% | $12.25B | |
| 36.00% | $12.98B | |
| -83.22% | $34.65B | |
| -6.85% | $22.61B | |
| -340.55% | $10.67B | |
| 184.27% | $17.47B | |
| -50.15% | $11.66B | |
| 40.21% | $13.05B | |
| 4.41% | $10.57B | |
| -36.73% | $25.38B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ascendis Pharma A/S using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ascendis Pharma A/S or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Ascendis Pharma A/S's ROE?
How is the ROE calculated for Ascendis Pharma A/S (ASND)?
What is the highest ROE for Ascendis Pharma A/S (ASND)?
What is the 3-year average ROE for Ascendis Pharma A/S (ASND)?
What is the 5-year average ROE for Ascendis Pharma A/S (ASND)?
How does the current ROE for Ascendis Pharma A/S (ASND) compare to its historical average?